Skip to main navigation
VIR logo

SEC Filing Details

SEC Filing Details

Document Details

Form
10-K
Filing Date
Mar 26, 2020
Document Date
Dec 31, 2019
Form Description
Annual report which provides a comprehensive overview of the company for the past year
Filing Group
Annual Filings
Company
Vir
Issuer
Vir Biotechnology, Inc.

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS

XBRL

XBRL Viewer
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
EX-101.CAL - XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
EX-101.DEF - XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE
EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
XML - XBRL INSTANCE DOCUMENT
  • Corporate Governance
    • Charters & Governance
    • Leadership
  • Press Releases
  • Events & Presentations
  • Stock Information
    • Stock Quote & Chart
    • Analyst Coverage
  • SEC Filings
  • Investor Resources
    • FAQ
    • Investor Contact
    • Email Alerts
  • Financial Information
    • Quarterly Results
  • About
    • Mission
    • Leadership
  • Science
    • Platforms
    • Literature Archive
  • Pipeline
    • Our Focus
    • Our Collaborators
  • Careers
    • Join Us
    • VIRtues
    • Job Opportunities
  • Contact
  • Investors
    • Corporate Governance
      • Charters & Governance
      • Leadership
    • Press Releases
    • Events & Presentations
    • Stock Information
      • Stock Quote & Chart
      • Analyst Coverage
    • SEC Filings
    • Investor Resources
      • FAQ
      • Investor Contact
      • Email Alerts
    • Financial Information
      • Quarterly Results
  • Print Page
  • Email Alerts
  • RSS Feeds
  • Investor Contact
  • About
    • Mission
    • Leadership
  • Science
    • Platforms
    • Literature Archive
  • Pipeline
    • Our Focus
    • Our Collaborators
  • Careers
    • Join Us
    • VIRtues
    • Job Opportunities
  • Contact
  • Investors
    • Corporate Governance
      • Charters & Governance
      • Leadership
    • Press Releases
    • Events & Presentations
    • Stock Information
      • Stock Quote & Chart
      • Analyst Coverage
    • SEC Filings
    • Investor Resources
      • FAQ
      • Investor Contact
      • Email Alerts
    • Financial Information
      • Quarterly Results

vir logo white

Vir Biotechnology, Inc.
499 Illinois Suite 500
San Francisco, CA 94158
415-906-4324

email: info@vir.bio

  • LinkedIn
  • Twitter
©  Vir Biotechnology All rights reserved.
  • Privacy Policy
  • Terms of Use